Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Passage BIO, Inc. | 185,776 | reported | 27 Feb 2020 | tx 2+219,612 |
| Compass Therapeutics, Inc. | 30,000 | reported | 18 Feb 2022 | tx 2+60,000 |
| Chemomab Therapeutics Ltd. | 23,768 | reported | 19 Apr 2021 | tx 1+23,768 |
| SpringWorks Therapeutics, Inc. | 15,318 | reported | 19 May 2022 | tx 18+54,423,136−7,152,307 |
| Audentes Therapeutics, Inc. | 9,000 | reported | 08 Oct 2017 | tx 2+18,000 |
| ALEXION PHARMACEUTICALS INC | 0 | reported | 27 Oct 2014 | tx 284+1,457,400−1,785,017 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2022 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 4,818 | 0.00 USD | |
| 19 May 2022 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 15,318 | 0.00 USD | deriv |
| 18 Feb 2022 | GRANT_AWARD | Compass Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 20 May 2021 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 1,106 | 0.00 USD | |
| 20 May 2021 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 6,998 | 0.00 USD | deriv |
| 27 Apr 2021 | SALE | SpringWorks Therapeutics, Inc. | 201 | 75.05 USD | |
| 28 Apr 2021 | SALE | SpringWorks Therapeutics, Inc. | 19,231 | 76.20 USD | |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 23,768 | 0.00 USD | deriv |
| 15 Apr 2021 | SALE | SpringWorks Therapeutics, Inc. | 1,057 | 75.01 USD | |
| 14 Apr 2021 | SALE | SpringWorks Therapeutics, Inc. | 511 | 75.08 USD | |
| 06 Aug 2020 | GRANT_AWARD | Compass Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 20 May 2020 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 7,464 | 0.00 USD | deriv |
| 12 Mar 2020 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 27 Feb 2020 | GRANT_AWARD | Passage BIO, Inc. | 33,836 | 0.00 USD | deriv |
| 27 Feb 2020 | GRANT_AWARD | Passage BIO, Inc. | 185,776 | 0.00 USD | deriv |
| 17 Sept 2019 | PURCHASE | SpringWorks Therapeutics, Inc. | 275,000 | 18.00 USD | |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 1,053,204 | — | |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 6,078,103 | — | |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 1,053,204 | — | deriv |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 6,078,103 | — | deriv |
| 12 Sept 2019 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 29,983 | 0.00 USD | deriv |
| 29 Mar 2019 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 40,000,000 | — | deriv |
| 29 Mar 2019 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 6,931,142 | — | deriv |
| 08 Oct 2017 | GRANT_AWARD | Audentes Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 24 Aug 2016 | GRANT_AWARD | Audentes Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |